COMMUNIQUÉS West-GlobeNewswire

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
10/11/2026
SEATTLE, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), ), a commercial stage biotechnology company that aims to translate the genetics of the [...]
Seer Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Revenue Guidance
10/11/2026
REDWOOD CITY, Calif., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced financial results for [...]
Braveheart Bio Reports Third Quarter 2026 Financial Results and Provides Business Update
10/11/2026
52-week data presented at AHA Scientific Sessions 2026 further strengthen BHB-1893’s potential differentiation, with encouraging clinical activity and support for a highly simplified dosing regimen LIONHEART-HCM oHCM [...]
Amneal Named BioSpace 2027 Best Place to Work, Ranking No.1 Among Large Employers
10/11/2026
Recognition marks second consecutive year Amneal has been named a BioSpace Best Place to Work BRIDGEWATER, N.J., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) [...]
Stereotaxis Reports 2026 Third Quarter Financial Results & Business Updates
10/11/2026
ST. LOUIS, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported business updates and financial [...]
Kura Oncology Reports Third Quarter 2026 Financial Results and Corporate Update
10/11/2026
– KOMZIFTI ® (ziftomenib) net product revenue grew 53% sequentially to $13.9 million; new patient starts increased 30% and total prescriptions grew 65% – – KOMZIFTI maintained majority share of new patient starts of the [...]
Lakefront to Present at the 2026 Jefferies Global Healthcare Conference in London
10/11/2026
Mechelen, Belgium; November 10, 2026, 22.01 CET; Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today announced that the Company will host a fireside chat at the 2026 Jefferies Global Healthcare Conference [...]
Inhibikase Therapeutics Announces Third Quarter 2026 Financial Results and Highlights Recent Activity
10/11/2026
WILMINGTON, Del., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001, a novel once-daily oral anti- [...]
Freenome Reports Third Quarter 2026 Financial Results
10/11/2026
– Third-quarter results reflect revenue of $183.5 million driven by the FDA approval of SimpleScreen™ CRC – – Entered the public market and raised gross proceeds of $310 million – BRISBANE, Calif., Nov. 10, 2026 (GLOBE [...]
Ascendis Pharma to Participate in the Jefferies London Healthcare Conference
10/11/2026
COPENHAGEN, Denmark, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that company executives will participate in a fireside chat at the Jefferies London Healthcare Conference on [...]
Preclinical Data Show Annamycin Makes Pancreatic Cancer Responsive to Checkpoint Inhibitors, Opening a Combination Path with Immunotherapies
10/11/2026
Inhibition of CD8+ T cells shortens survival in Annamycin-treated mice, demonstrating the immune system is a functional contributor to Annamycin’s antitumor activity, not a bystander Annamycin achieves substantially [...]
Autonomix Medical Granted New U.S. Patent Strengthening Proprietary Catheter-Based Sensing Technology
10/11/2026
Latest patent expands intellectual property protection for advanced physiological signal acquisition and processing THE WOODLANDS, TX, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix [...]
Bon Secours Mercy Health names Shon Baker foundation president, chief philanthropy officer
10/11/2026
Veteran philanthropy executive will strengthen donor partnerships to advance the ministry’s mission, extend its impact and support continued growth CINCINNATI, Nov. 10, 2026 (GLOBE NEWSWIRE) -- CINCINNATI, Ohio (Nov. 10 [...]
Inviah Healthcare Technology Platform Moves from Beta to Full Launch in Illinois to Bring Doctors and Quality Healthcare Directly to Patients’ Homes
10/11/2026
Physician-led healthcare company connects patients through the Inviah mobile app with credentialed doctors on demand, making medical care more accessible and convenient CHICAGO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Inviah [...]
Priovant Announces Publication of Phase 2 BEACON Results for Brepocitinib in Cutaneous Sarcoidosis in JAMA Dermatology
10/11/2026
At Week 16, 69% of participants receiving brepocitinib 45 mg achieved "Clear" or "Almost Clear" skin, with at least a 2-category improvement, compared with 0% receiving placebo Improvements in skin disease activity were [...]
Pain clinics in Ontario call for transparency amid concerns over future treatment access
10/11/2026
Save Pain Clinics seeks answers on potential changes to OHIP-funded nerve blocks and interventional pain injections for chronic pain TORONTO, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Patients and clinicians across Ontario are [...]
Novartis ianalumab two-year data at ACR show further improvements in Sjögren’s disease activity
10/11/2026
Patients continuing ianalumab saw further improvement in systemic disease activity through Week 108, with no new safety findings 1 Nearly two-thirds of patients on continuous ianalumab reached low disease activity at [...]
GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 octobre 2026
10/11/2026
DECLARATION RELATIVE AU NOMBRE DE DROITS DE VOTE ET D'ACTIONS COMPOSANT LE CAPITAL DE LA SOCIETE En application de l'article L. 233-8 II du code de commerce et de l’article 222-12-5 du règlement général de l’AMF, les [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
10/11/2026
Nantes, le 10 novembre 2026 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement général de l’AMF, OSE Immunotherapeutics (ISIN : FR0012127173 ; Mnémo : OSE), une société de [...]

Pages